William Hood & Company Research
Advisory Approach
William Hood & Company is a premier, boutique investment bank founded in 2018 by William Hood and Jill Staib, bringing together 35 years of combined experience in consumer products investment banking and health & wellness operating leadership. The firm operates with a differentiated thesis: they marry traditional investment banking expertise with brand building and operational knowledge to deliver superior outcomes for health and wellness consumer products companies.
The firm's philosophy centers on being "passionate champions of the health and wellness industry" with deep knowledge of both fundamentals and emerging trends. They position themselves not merely as transactional advisors, but as long-term partners who engage with companies well before a sale process, providing strategic guidance on product portfolio management, board composition, and exit planning. Their "partnership model" encourages early engagement to support clients throughout their business lifecycle.
William Hood & Company differentiates through several key attributes: (1) Unparalleled storytelling capability that transforms complex brand propositions into compelling investment theses, (2) Deep category expertise spanning nutrition & supplementation, beauty & personal care, and active lifestyle, (3) Global buyer relationships cultivated through decades of cross-border transactions, and (4) Bespoke process design tailored to each client's unique attributes rather than template-driven execution.
Sector Focus
The firm's practice is concentrated exclusively on the health and wellness consumer products sector. This focus spans three primary verticals:
Nutrition & Supplementation: Vitamins, minerals, supplements (VMS), probiotics, functional nutrition, protein products, and practitioner-channel supplements. The firm has completed landmark transactions including Bonafide Health ($425M sale to Pharmavite), Hiya ($205M sale to USANA), and advisory roles on Metagenics, YouTheory, and Persona Nutrition.
Beauty & Personal Care: Clean beauty, plant-powered cosmetics, and personal care products with natural/organic positioning. Notable transactions include OLLY (sale to Unilever), W3ll People (sale to e.l.f. Beauty), and advisory on numerous DTC beauty brands.
Functional Food & Beverage: Plant-based superfoods, functional beverages, hydration products, and better-for-you snacks. Transaction experience includes Navitas Organics ($38.5M sale to Laird Superfood), Liquid I.V. (sale to Unilever), and advisory on plant-based nutrition platforms.
Deal Track Record
William Hood & Company has established an exceptional track record in health & wellness M&A. Recent representative transactions include:
2024-2026: Hiya Health sold 78.8% stake to USANA for $205M (exclusive financial advisor, 2024); Better Being acquired by Snapdragon Capital/SVP syndicate (co-financial advisor, 2025); Navitas LLC acquired by Laird Superfood for $38.5M (exclusive financial advisor, 2026).
2023: Bonafide Health acquired by Pharmavite/Otsuka for $425M in cash (lead financial advisor), representing an industry-defining transaction in women's health; numerous strategic sell-side mandates in the $50M-$500M range.
2021: Metagenics acquired by Gryphon Investors from Alticor (co-lead financial advisor with Nomura); Nutrition21 advised on sale to RoundTable Healthcare Partners to form Everwell Health platform.
2019-2020: Habit (personalized nutrition) acquired by Viome from Campbell Soup (exclusive financial advisor to Campbell/Habit, 2019); Nestlé Health Science investment in Before Brands (Greg Horn of William Hood & Company advised).
Historical Major Transactions (William Hood's career experience spanning prior firms): Atrium Innovations/Garden of Life sold to Nestlé for $2.4B; Holland & Barrett (UK) sold to LetterOne Retail for $2.3B; Nature's Bounty Company sold from Carlyle Group to KKR; Schiff Nutrition sold to Reckitt Benckiser for $1.4B; Iovate sold to Xiwang (China) for $850M; Avid Health (Lil' Critters/Vitafusion) sold to Church & Dwight for $650M; Emergen-C sold to Pfizer for $350M.
The firm's principals have been involved in 100+ transactions throughout their careers, with aggregate transaction value exceeding $15 billion. Current William Hood & Company transaction count since founding exceeds 30 completed deals.
Process & Fee Structure
William Hood & Company runs highly bespoke, strategic-only sell-side processes. Their approach emphasizes:
-
Exhaustive buyer outreach: They leverage their global network to identify and engage the universe of strategic and financial buyers, with particular strength in CPG conglomerates (Unilever, Nestlé, P&G), health-focused strategics (Pharmavite/Otsuka, Church & Dwight), and middle-market private equity firms specializing in consumer/healthcare.
-
Differentiated investment theses: Rather than generic positioning, they craft custom narratives that highlight unique brand attributes, DTC performance metrics, clinical substantiation (where applicable), and whitespace expansion opportunities.
-
Strategic-only processes: They maintain disciplined standards by running processes that attract qualified strategic buyers and financial sponsors, avoiding speculative approaches that waste management time.
-
Transaction type flexibility: Experienced across majority sales, minority recapitalizations, corporate carve-outs, divestitures, and growth capital raises.
Typical engagement timeline: 6-9 months from engagement to close. The firm typically works with founder-owned and sponsored businesses in the $25M-$500M enterprise value range, with selective engagements below $10M for exceptional growth stories.
Buyer Network
William Hood & Company's buyer network is a core differentiator. Relationships include:
Strategic Buyers: Unilever (multiple transactions: OLLY, Liquid I.V.), Nestlé Health Science (Atrium/Garden of Life, Persona Nutrition, Before Brands investment), Procter & Gamble (VOOST acquisition), Pharmavite/Otsuka (Bonafide Health), Church & Dwight (Avid Health), Reckitt Benckiser (Schiff Nutrition), e.l.f. Beauty (W3ll People), USANA (Hiya), Campbell Soup (Habit disposition).
Private Equity Firms: Gryphon Investors (Metagenics), Snapdragon Capital Partners (Better Being), Nexus Capital Management (Navitas/Laird Superfood), RoundTable Healthcare Partners (Everwell Health/Nutrition21), New Mountain Capital (Jarrow), CCMP (Jamieson), KKR (Nature's Bounty), Carlyle Group (Nature's Bounty), The Riverside Company (multiple mandates), and dozens of lower-middle market health & wellness focused sponsors.
International Reach: The firm has completed cross-border transactions with European buyers (Eurazeo Brands for Beekman 1802, LetterOne Retail for Holland & Barrett, Xiwang for Iovate) and Asian strategic acquirers (Otsuka/Pharmavite, Takeda for Unipharm).
Competitive Positioning
William Hood & Company distinguishes itself from other lower middle market M&A advisors through:
-
Category specialization: While generalist banks claim consumer expertise, William Hood & Company lives exclusively in health & wellness. Their team attends industry conferences (Expo West, Expo East, NBJ Summit, Supply Side West), publishes thought leadership, and maintains active dialogue with industry participants. This category depth translates into more credible buyer conversations and nuanced valuation frameworks.
-
Operating credibility: Co-founder Jill Staib is a former health & wellness industry executive, not a career banker. Managing Directors like Greg Horn (former CEO of Garden of Life) bring operator perspective. This operational resonance builds trust with founder-owners and facilitates deeper due diligence support.
-
Global network with boutique service: William Hood's personal background (UK and Hong Kong upbringing, global transaction career) and the firm's international deal flow create buyer access typically reserved for bulge bracket banks. Yet the firm delivers senior-attention, bespoke service that only a boutique can provide.
-
Content and storytelling excellence: The firm's marketing materials, management presentations, and investment teasers are consistently cited by clients as exceptional. Their "unparalleled storytelling capability" transforms brand equity into financial value.
Not a Fit If
William Hood & Company typically declines:
- Businesses below $10M enterprise value (exceptions made for exceptional DTC growth stories)
- Sectors outside health & wellness consumer products (no industrial, tech, energy, or financial services)
- Pure asset sales or distressed situations (focus on going-concern enterprises with growth narratives)
- Founders seeking limited-process or quick-sale approaches (the firm's value is in comprehensive, strategic processes)
- Companies lacking authentic health/wellness positioning (generic consumer products, traditional CPG without wellness attributes)
Team
William Hood – Managing Director & Co-Founder. 25+ years investment banking experience. Previously Managing Director at Houlihan Lokey where he founded and led the Consumer Health and Wellness practice. Prior partner at specialized investment banking boutique. Began career at PaineWebber. Well-known global expert in consumer products and health & wellness M&A. Frequent speaker at Expo West, Expo East, NBJ Summit. Serves on Editorial Board of Nutrition Business Journal. Board member of Vitamin Angels and Greenwich Emergency Medical Services. B.S. from Georgetown University. FINRA Series 7, 24, 63, 79.
Jill Staib – Managing Director & Co-Founder. Health & wellness industry executive with 15+ years operating experience. Brings operator perspective and brand-building expertise to complement investment banking capabilities. Board member of Vitamin Angels U.K.
Greg Horn – Managing Director & Partner, Head of Practice: Ingredients & Functional Nutrition. Former CEO of Garden of Life (sold to Nestlé). recognized industry thought leader and speaker at NBJ Summit. Deep expertise in functional ingredients, nutrition science, and practitioner-channel supplements.
Kevin McGee – Managing Director, Head of Practice: Active Lifestyle. Focuses on fitness, sports nutrition, and performance wellness brands.
Daniel Grubbs – Managing Director, Head of Practice: Food & Beverage. Specializes in functional foods, plant-based nutrition, and better-for-you beverages.
Jeremy Vallesteros – Vice President. Focuses on nutrition & supplementation transactions.
Javed Narejo – Vice President. Joined in 2026 from prior investment banking role.
Monique Romero – Chief Financial Officer & FINOP. Responsible for financial operations and FINRA compliance.
The firm maintains a lean team of approximately 10-15 professionals, ensuring senior-level attention on all engagements.
Geographic Coverage
Headquartered in New York, NY (1330 Avenue of the Americas). While primarily focused on U.S.-based sellers, the firm's global buyer network and international transaction experience enable cross-border transactions. William Hood's international background and frequent travel to Europe and Asia support non-U.S. buyer outreach. Recent transactions demonstrate global capability: Bonafide Health to Japanese-owned Pharmavite; Beekman 1802 to European private equity Eurazeo Brands; and numerous sales to multinational strategics.